Insulet (NASDAQ: PODD) reported Q1 EPS of $0.40, $0.17 better than the analyst estimate of $0.23. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $288.19 million.

GUIDANCE:

For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.

For earnings history and earnings-related data on Insulet (PODD) click here.